Activin a and follistatin as biomarkers for ectopic pregnancy and missed abortion

Disease Markers

Volumn 35, Issue 5, 2013, Pages 497-503

  Daponte, Alexandros ^a   Deligeoroglou, Efthimios ^b   Garas, Antonios ^a   Pournaras, Spyros ^b   Hadjichristodoulou, Christos ^a   Messinis, Ioannis E ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; CHORIONIC GONADOTROPIN BETA SUBUNIT; FOLLISTATIN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECTOPIC PREGNANCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSED ABORTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; VAGINA BLEEDING;

ABORTION, MISSED; ACTIVINS; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FOLLISTATIN; HUMANS; PREGNANCY; PREGNANCY, ECTOPIC;

EID: 84890330822     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/969473     Document Type: Article

References (37)

1. J. Cartwright, W. C. Duncan, H. O. D. Critchley, and A. W. Horne, "Serum biomarkers of tubal ectopic pregnancy: current candidates and future possibilities," Reproduction, vol. 138, no. 1, pp. 9-22, 2009.
2. M. E. Rausch,M.D. Sammel, P. Takacs, K. Chung, A. Shaunik, and K. T. Barnhart, "Development of a multiple marker test for ectopic pregnancy," Obstetrics and Gynecology, vol. 117, no. 3, pp. 573-582, 2011.
3. A.Daponte, S. Pournaras, E. Zintzaras et al., "The value of a single combined measurement of VEGF, glycodelin, progesterone, PAPP-A, HPL and LIF for differentiating between ectopic and abnormal intrauterine pregnancy," Human Reproduction, vol. 20, no. 11, pp. 3163-3166, 2005.
4. J. L. Shaw, E. P. Diamandis, A. Horne, K. Barnhart, T. Bourne, and I. E. Messinis, "Ectopic pregnancy," Clinical Chemistry, 2012.
5. M. Wakatsuki, Y. Shintani, M. Abe, Z.-H. Liu, K. Shitsukawa, and S. Saito, "Immunoradiometric assay for follistatin: serum immunoreactive follistatin levels in normal adults and pregnant women,"The Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 2, pp. 630-634, 1996.
6. T. K. Woodruff, P. Sluss, E.Wang, I. Janssen, andM. S.Mersol-Barg, "Activin A and follistatin are dynamically regulated during human pregnancy," The Journal of Endocrinology, vol. 152, no. 2, pp. 167-174, 1997.
7. E. M. Wallace, B. Marjono, K. Tyzack, and S. Tong, "First trimester levels of inhibins and activin A in normal and failing pregnancies," Clinical Endocrinology, vol. 60, no. 4, pp. 484-490, 2004.
8. A. Prakash, S. Laird, E. Tuckerman, T. C. Li, and W. L. Ledger, "Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage," Fertility and Sterility, vol. 83, no. 6, pp. 1758-1763, 2005.
9. R. L. Jones, J. K. Findlay, P. G. Farnworth, D. M. Robertson, E. Wallace, and L. A. Salamonsen, "Activin A and inhibin a differentially regulate human uterine matrix metalloproteinases: Potential interactions during decidualization and trophoblast invasion," Endocrinology, vol. 147, no. 2, pp. 724-732, 2006.
10. P. Florio, F. M. Severi, C. Bocchi et al., "Single serum activin A testing to predict ectopic pregnancy,"The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 5, pp. 1748-1753, 2007.
11. J. Johns, S.Muttukrishna, M. Lygnos, N. Groome, and E. Jauniaux, "Maternal serum hormone concentrations for prediction of adverse outcome in threatened miscarriage," Reproductive BioMedicine Online, vol. 15, no. 4, article no. 2969, pp. 413-421, 2007.
12. E. Kirk, A. T. Papageorghiou, B. Van Calster et al., "The use of serum inhibin A and activin A levels in predicting the outcome of 'pregnancies of unknown location'," Human Reproduction, vol. 24, no. 10, pp. 2451-2456, 2009.
13. P. Florio, F. M. Reis, R. Battista et al., "Serum activin A levels are lower in tubal than intrauterine spontaneously conceived pregnancies," Gynecological Endocrinology, vol. 27, no. 6, pp. 391-395, 2011.
14. J.Warrick, A. Gronowski, C. Moffett, Q. Zhao, E. Bishop, and A. Woodworth, "Serum activin A does not predict ectopic pregnancy as a single measurement test, alone or as part of a multi-marker panel including progesterone and hCG," Clinica Chimica Acta, vol. 413, no. 7-8, pp. 707-711, 2012.
15. D. M. de Kretser, L. M. Foulds, M. Hancock, and D. M. Robertson, "Partial characterization of inhibin, activin, and follistatin in the term human placenta," The Journal of Clinical Endocrinology andMetabolism, vol. 79, no. 2, pp. 502-507, 1994.
16. F. Petraglia, A. Gallinelli, D. de Vita, K. Lewis, L. Mathews, andW. Vale, "Activin at parturition: changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes," Obstetrics and Gynecology, vol. 84, no. 2, pp. 278-282, 1994.
17. S. Luisi, P. Florio, D. D'Antona et al., "Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage," European The Journal of Endocrinology, vol. 148, no. 2, pp. 233-236, 2003.
18. P. Florio, S. Luisi, P. Ciarmela, F. M. Severi, C. Bocchi, and F. Petraglia, "Inhibins and activins in pregnancy," Molecular and Cellular Endocrinology, vol. 225, no. 1-2, pp. 93-100, 2004.
19. S. Muttukrishna, E. Jauniaux, N. Greenwold et al., "Circulating levels of inhibin A, activin A and follistatin in missed and recurrentmiscarriages," Human Reproduction, vol. 17,no. 12,pp. 3072-3078, 2002.
20. P. Florio,M. Gabbanini, L. E. Borges et al., "Activins and related proteins in the establishment of pregnancy," Reproductive Sciences, vol. 17, no. 4, pp. 320-330, 2010.
21. S. Muttukrishna, C. Bearfield, J. Johns, and E. Jauniaux, "Inhibin, activin, follistatin, activin receptors and α-glycan gene expression in the villous tissue of miscarriage patients," Molecular Human Reproduction, vol. 10, no. 11, pp. 793-798, 2004.
22. B. A. Refaat, A. O. Bahathiq, S. Sockanathan, R. L. Stewart, M. Wells, and W. L. Ledger, "Production and localization of activins and activin type IIA and IIB receptors by the human endosalpinx," Reproduction, vol. 128, no. 2, pp. 249-255, 2004.
23. X. Wen, A. J. Tozer, D. Li, S. M. Docherty, T. Al-Shawaf, and R. K. Iles, "Human granulosa-lutein cell in vitro production of progesterone, inhibin A, inhibin B, and activin A are dependent on follicular size and not the presence of the oocyte," Fertility and Sterility, vol. 89, no. 5, pp. 1406-1413, 2008.
24. C. Bearfield, E. Jauniaux, N. Groome, I. L. Sargent, and S. Muttukrishna, "The secretion and effect of inhibin A, activin A and follistatin on first-trimester trophoblasts in vitro," European The Journal of Endocrinology, vol. 152, no. 6, pp. 909-916, 2005.
25. R. L. Jones, L. A. Salamonsen, Y. C. Zhao, J.-F. Ethier, A. E. Drummond, and J. K. Findlay, "Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization," MolecularHuman Reproduction, vol. 8, no. 4, pp. 363-374, 2002.
26. M. Birdsall, W. Ledger, N. Groome, H. Abdalla, and S. Muttukrishna, "Inhibin A and activin A in the first trimester of human pregnancy," The Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1557-1560, 1997.
27. G. M. Lockwood, W. L. Ledger, D. H. Barlow, N. P. Groome, and S. Muttukrishna, "Measurement of inhibin and activin in early human pregnancy: demonstration of fetoplacental origin and role in prediction of early-pregnancy outcome," Biology of Reproduction, vol. 57, no. 6, pp. 1490-1494, 1997.
28. S.Muttukrishna, P. G. Knight, N. P. Groome, C.W. G. Redman, andW. L. Ledger, "ActivinAand inhibinAas possible endocrine markers for preeclampsia," The Lancet, vol. 349, no. 9061, pp. 1285-1288, 1997.
29. M. E. Schneider-Kolsky, U. Manuelpillai, K. Waldron, A. Dole, and E. M. Wallace, "The distribution of activin and activin receptors in gestational tissues across human pregnancy and during labour," Placenta, vol. 23, no. 4, pp. 294-302, 2002.
30. P. A. Fowler, L. W. Evans, N. P. Groome, A. Templeton, and P. G. Knight, "A longitudinal study of maternal serum inhibin-A inhibin-B, activin-A activin-AB, pro-αC and follistatin during pregnancy," Human Reproduction, vol. 13, no. 12, pp. 3530-3536, 1998.
31. A. E. O'Connor, J. R. McFarlane, S. Hayward, T. Yohkaichiya, N. P. Groome, and D. M. De Kretser, "Serum activin A and follistatin concentrations during human pregnancy: a crosssectional and longitudinal study," Human Reproduction, vol. 14, no. 3, pp. 827-832, 1999.
32. M. Schneider-Kolsky, D. D'Antona, L.W. Evans et al., "Maternal serum total activin A and follistatin in pregnancy and parturition," British Journal of Obstetrics and Gynaecology, vol. 107, no. 8, pp. 995-1000, 2000.
33. E. P. Tierney and L. C. Giudice, "Role of activin A as a mediator of invitroendometrial stromal cell decidualizationvia the cyclic adenosine monophosphate pathway," Fertility and Sterility, vol. 81, no. 1, pp. 899-903, 2004.
34. T. R. Kumar, "Too many follistatins: racing inside and getting out of the cell," Endocrinology, vol. 146, no. 12, pp. 5048-5051, 2005.
35. V. Maguer-Satta, L. Bartholin, S. Jeanpierre et al., "During hematopoiesis, expression of FLRG, a novel activin A ligand, is regulated by TGF-α," Experimental Hematology, vol. 29, no. 3, pp. 301-308, 2001.
36. G. J. Burton, E. Jauniaux, and A. L. Watson, "Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the boyd collection revisited," The American Journal of Obstetrics and Gynecology, vol. 181, no. 3, pp. 718-724, 1999.
37. J.Warrick, A. Gronowski, C. Moffett, Q. Zhao, E. Bishop, and A. Woodworth, "Serum activin A does not predict ectopic pregnancy as a single measurement test, alone or as part of a multi-marker panel including progesterone and hCG," Clinica Chimica Acta, vol. 413, no. 7-8, pp. 707-711, 2012.